At a study of the mechanism that NK-mediated cytotoxicity to breast cancer targets, unexpectedly, anti-CD58 mAb failed to inhibit NK-mediated killing but instead mediated the enhanced cytotoxicity associated with CD58 expression, albeit CD2 blockade mildly reduced cytotoxicity (145). This evidence concerns the gene CD58 and breast cancer.